Oligometastasis

24 registered clinical trials studyying Oligometastasis — 16 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Trial of Oligometastasis SBRT With Immediate, Simulation-Free Treatment Delivery (OLIGO-SWIFT) NCT07079098	Case Comprehensive Cancer Center	Phase 1
Not Yet Recruiting	Randomized Trial of stAndard of Care With or Without Metastases-directed Stereotactic Body Radiation Therapy i NCT07413523	Istituto Clinico Humanitas	N/A
Recruiting	SMC Radiation Oncology SABR Cohort for Oligometastasis NCT07121335	Samsung Medical Center	—
Recruiting	stereOtactic Body RadIothErapy for exTracranial oligomeTastAtic Breast Cancer: Multi Institutional Retrospecti NCT07397585	Istituto Clinico Humanitas	—
Recruiting	Ablation of Pulmonary Oligometastasis Combined With System for Advanced Hepatocellular Carcinoma NCT06644430	Sun Yat-sen University	—
Recruiting	Stereotactic Ablative Radiotherapy (SABR) for the Treatment of Patients With Metastatic Cancer, ID-COMET Trial NCT06563388	Roswell Park Cancer Institute	Phase 3
Recruiting	Ablation of Oligometastasis Combined With Lenvatinib and PD-1 Inhibitor for Advanced Hepatocellular Carcinoma NCT06550921	Sun Yat-sen University	N/A
Not Yet Recruiting	Outcomes of Local Treatment for Oligometastatic Prostate Cancer Diagnosed Using PSMA PET Imaging: OLIGOMET Stu NCT06430411	Medical University of Vienna	—
Recruiting	Metastasis-directed Therapy for Oligometastases of Breast Cancer NCT06135714	Tokyo Medical and Dental University	Phase 3
Recruiting	Metastasis-directed Therapy for Oligorecurrent Prostate Cancer NCT05352178	Universitaire Ziekenhuizen KU Leuven	Phase 3
Unknown	Toripalimab in Combination With Platinum-based Chemotherapy for Mutation-negative Stage IV Oligometastatic NSC NCT05055583	Tang-Du Hospital	Phase 2
Recruiting	Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-direc NCT04787744	VA Office of Research and Development	Phase 2 / Phase 3
Recruiting	Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE) NCT04498767	European Organisation for Research and Treatment of Cancer - EORTC	N/A
Unknown	Stereotactic Body Radiotherapy With or Without Darolutamide for OligoRecurrent Prostate Cancer NCT04641078	University Hospital, Ghent	Phase 2
Unknown	Microwave Ablation Combined With Chemotherapy in the Treatment of Pancreatic Cancer Oligohepatic Metastasis NCT04677192	Fudan University	Phase 2
Unknown	Sintilimab After Stereotactic Ablation Brachytherapy for Refractory Oligometastatic Non-Small Cell Lung Cancer NCT04486287	Tianjin Medical University Second Hospital	Phase 2
Recruiting	Radical Local vs. Palliative Therapy for Breast Cancer Patientts With Ipsilateral Humerus or Sternum Oligometa NCT04158843	xuexin he	N/A
Unknown	Camrelizumab After Completion of Radiotherapy for Oligometastatic Nasopharyngeal Carcinoma NCT04221516	Nanfang Hospital, Southern Medical University	Phase 2
Active Not Recruiting	Immunotherapy, Chemotherapy, Radiotherapy and Surgery for Synchronous Oligo-metastatic NSCLC NCT03965468	ETOP IBCSG Partners Foundation	Phase 2
Recruiting	Role of Ablative Radiotherapy in the Management of Metastatic Disease: A Patient Data Registry NCT04085029	Duke University	—
Active Not Recruiting	Salvage Oligometastasectomy and Radiation Therapy in Recurrent Prostate Cancer NCT03796767	University of Utah	Phase 2
Active Not Recruiting	Comparison of Intermittent Androgen Deprivation Therapy With or Without Irradiation Recovery in Prostate Cance NCT03630666	Institut Cancerologie de l'Ouest	N/A
Recruiting	Feasibility of Online MR-guided Radiotherapy on a 1.5T MR-Linac NCT04172753	University Hospital Tuebingen	N/A
Recruiting	Chemotherapy With or Without Radiation or Surgery in Treating Participants With Oligometastatic Esophageal or NCT03161522	M.D. Anderson Cancer Center	Phase 2